Maryam ALem
1 
, Mahoor Abedzadeh
1 , Zahra Golestani Hotkani
2 , Parham Mashouf
1 , Neda Kianpour
3 , Leila ALem
1* 1 Nickan Research Institute, Isfahan, Iran
2 Department of Bioscience, University of Milan, 20133 Milan, Italy
3 Department of Biotechnology, Biohouse, Inland Norway University of Applied Sciences, Hamar, Hedmark, Norway
Implication for health policy/practice/research/medical education:
Recent studies have found no conclusive evidence to suggest an increased risk of cancer in immunoglobulin A nephropathy.
Please cite this paper as: ALem M, Abedzadeh M, Golestani Hotkani Z, Mashouf P, Kianpour N, ALem L. Cancer in IgA nephropathy; a letter to the editor on current findings. J Nephropharmacol. 2024;13(1):e10642. DOI: 10.34172/npj.2023.10642.